Round up


3 years


Available in

0 Countries

of 155 total



last updated: n/a

Overall Ratings


Global Rank


Currently not visible

Top 25 Overall

0 Countries

Not in any top 25

Global Rank Positions
Read more
The global burden of chronic obstructive pulmonary disease (COPD) is increasing, and the disease is projected to be the third leading cause of death and fifth leading cause of overall disability worldwide by 2020. It is one of the leading causes of disability worldwide and is the most common disease whose prevalence and mortality rates continue to rise.

Therefore, COPD has gained global interest as a major public health concern and is currently the focus of intense research, clinical focus, and therapeutic development due to its increasing prevalence, mortality, and disease burden on individuals and society.

CHEST COPD: Current Excellence and Future Development aims to disseminate cutting-edge findings on COPD and provide a unique, intimate platform for clinicians, experts, and specialists to come together for discussion on current best practices and future directions in diagnosis, treatment, and therapeutic innovations.

Session themes:
•History and burden of COPD
•Polymorbidity in COPD
•Infections and exacerbations in COPD
•Current treatment of COPD
•The future of COPD

Using Elsevier's new CHEST2017 app, you can browse the scientific programme by days, topic or speaker, create your own personal programme, locate rooms and exhibitor stands on the floor plans, and more. Before first use, you will need to download the latest conference data and then afterwards, you can use the app offline.
Read more
Read more